CS logo
small CS logo
Jeffrey H. Margolis, MD

Royal Oak, Michigan, United States
Hematologist in Royal Oak, Michigan
3577 13 Mile Rd, Royal Oak, MI 48073

About Jeffrey H. Margolis, MD


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Point Therapeutics
2
Total Rows: 1

Clinical Trials at Jeffrey H. Margolis, MD


During the past decade, Jeffrey H. Margolis, MD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
2006-01-01
Terminated
400
Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
2006-02-01
Terminated
400

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsPoint Therapeutics: 2Point Therapeutics: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Jeffrey H. Margolis, MD


According to Clinical.Site data, the most researched conditions in "Jeffrey H. Margolis, MD" are "Carcinoma, Non-Small Cell Lung" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Lung Cancer" (1 trials), "Neoplasms, Lung" (1 trials) and "Neoplasms, Pulmonary" (1 trials). Many other conditions were trialed in "Jeffrey H. Margolis, MD" in a lesser frequency.

Clinical Trials Intervention Types at Jeffrey H. Margolis, MD


Most popular intervention types in "Jeffrey H. Margolis, MD" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "docetaxel" (1 trials), "pemetrexed" (1 trials), "talabostat" (1 trials) and "talabostat mesylate" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Jeffrey H. Margolis, MD


The vast majority of trials in "Jeffrey H. Margolis, MD" are 2 trials for "All" genders.

Clinical Trials Status at Jeffrey H. Margolis, MD


Currently, there are NaN active trials in "Jeffrey H. Margolis, MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Jeffrey H. Margolis, MD, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Jeffrey H. Margolis, MD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusTerminated: 2Terminated: 2